Document is current
Any future updates will be listed below
-
Authors
Li, Dan
Liang, Tianyuzhou
Hutchins, Laura E
Wolfarth, Alexandra A
Ferrando-Martinez, Sara
Lee, Byung Ha
Ho, Mitchell https://orcid.org/0000-0002-9152-5405
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct05003895 at ClinicalTrials.govDocuments that mention this clinical trial
rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors
https://doi.org/10.1136/jitc-2024-008989
A phase I study of GPC3 targeted CAR-T cell therapy in advanced GPC3-expressing hepatocellular carcinoma (HCC).
https://doi.org/10.1200/jco.2023.41.4_suppl.tps624
-
Funding
Funding for this research was provided by:
Center for Cancer Research (CRADA with NeoImmuneTech, Inc.)
Center for Cancer Research (Z01 BC010891)
Center for Cancer Research (ZIA BC010891)
- License Information
